Effect of acute physiological elevations of insulin on circulating androgen levels in nonobese women

Michael P. Diamondf, David A. Grainger, Andrea J. Laudano, Kathleen Starick-Zych, Ralph A. Defronzo

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

Extreme pharmacological elevation of the circulating insulin level acutely lowers dehydroepiandrosterone sulfate (DHEAS) levels. To assess whether more physiological elevations in plasma insulin (due to exogenous infusion or endogenous secretion) would have similar effects, we examined the levels of DHEAS, androstenedione, testosterone, and free testosterone before and after euglycemic hyperinsulinemic and hyperglycemic hyperinsulinemic clamp studies. Studies were performed in women within 20% of ideal body weight after an overnight fast. Androgen levels were measured before and at the conclusion of studies in which either insulin was infused exogenously at 1 mU/kg·min or endogenous insulin secretion was stimulated for 2 h by elevation of the plasma glucose concentration by 125 mg/dL above basal levels by an exogenous glucose infusion. Basal plasma DHEAS (6.2 ± 0.5 μmol/L) declined to 5.2 ± 0.4 μmol/L (P < 0.001) during the euglycemic insulin clamp, without any significant change in testosterone, free testosterone, or androstenedione. During the hyperglycemic clamp, DHEAS fell from 6.7 ± 0.5 to 5.1 ± 0.4 μmol/h (P < 0.001) in response to endogenous hyperinsulinemia; plasma testosterone, free testosterone, and androstenedione did not change significantly. There was no correlation between the elevation in plasma insulin concentration and the fall in DHEAS during either the euglycemic or hyperglycemic clamps. However, the magnitude of fall of DHEAS was directly correlated with the initial DHEAS level in both the euglycemic (r = 0.51; P < 0.05) and hyperglycemic (r = 0.75; P < 0.01) studies. This association of hyperinsulinemia with a reduction of circulating levels of DHEAS, but not other C-19 steroids (e.g. testosterone and androstenedione) may reflect differential mechanisms by which DHEAS levels are regulated and suggests that insulin either inhibits its biosynthesis and/or secretion, or enhances its MCR.

Original languageEnglish (US)
Pages (from-to)883-887
Number of pages5
JournalJournal of Clinical Endocrinology and Metabolism
Volume72
Issue number4
DOIs
StatePublished - Jan 1 1991
Externally publishedYes

Fingerprint

Dehydroepiandrosterone Sulfate
Androgens
Insulin
Testosterone
Androstenedione
Clamping devices
Plasmas
Hyperinsulinism
Glucose
Ideal Body Weight
Glucose Clamp Technique
Biosynthesis
Steroids
Association reactions
Pharmacology

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Endocrinology
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Effect of acute physiological elevations of insulin on circulating androgen levels in nonobese women. / Diamondf, Michael P.; Grainger, David A.; Laudano, Andrea J.; Starick-Zych, Kathleen; Defronzo, Ralph A.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 72, No. 4, 01.01.1991, p. 883-887.

Research output: Contribution to journalArticle

Diamondf, Michael P. ; Grainger, David A. ; Laudano, Andrea J. ; Starick-Zych, Kathleen ; Defronzo, Ralph A. / Effect of acute physiological elevations of insulin on circulating androgen levels in nonobese women. In: Journal of Clinical Endocrinology and Metabolism. 1991 ; Vol. 72, No. 4. pp. 883-887.
@article{61f6b7206f1b4f6bb24195201d1f1762,
title = "Effect of acute physiological elevations of insulin on circulating androgen levels in nonobese women",
abstract = "Extreme pharmacological elevation of the circulating insulin level acutely lowers dehydroepiandrosterone sulfate (DHEAS) levels. To assess whether more physiological elevations in plasma insulin (due to exogenous infusion or endogenous secretion) would have similar effects, we examined the levels of DHEAS, androstenedione, testosterone, and free testosterone before and after euglycemic hyperinsulinemic and hyperglycemic hyperinsulinemic clamp studies. Studies were performed in women within 20{\%} of ideal body weight after an overnight fast. Androgen levels were measured before and at the conclusion of studies in which either insulin was infused exogenously at 1 mU/kg·min or endogenous insulin secretion was stimulated for 2 h by elevation of the plasma glucose concentration by 125 mg/dL above basal levels by an exogenous glucose infusion. Basal plasma DHEAS (6.2 ± 0.5 μmol/L) declined to 5.2 ± 0.4 μmol/L (P < 0.001) during the euglycemic insulin clamp, without any significant change in testosterone, free testosterone, or androstenedione. During the hyperglycemic clamp, DHEAS fell from 6.7 ± 0.5 to 5.1 ± 0.4 μmol/h (P < 0.001) in response to endogenous hyperinsulinemia; plasma testosterone, free testosterone, and androstenedione did not change significantly. There was no correlation between the elevation in plasma insulin concentration and the fall in DHEAS during either the euglycemic or hyperglycemic clamps. However, the magnitude of fall of DHEAS was directly correlated with the initial DHEAS level in both the euglycemic (r = 0.51; P < 0.05) and hyperglycemic (r = 0.75; P < 0.01) studies. This association of hyperinsulinemia with a reduction of circulating levels of DHEAS, but not other C-19 steroids (e.g. testosterone and androstenedione) may reflect differential mechanisms by which DHEAS levels are regulated and suggests that insulin either inhibits its biosynthesis and/or secretion, or enhances its MCR.",
author = "Diamondf, {Michael P.} and Grainger, {David A.} and Laudano, {Andrea J.} and Kathleen Starick-Zych and Defronzo, {Ralph A.}",
year = "1991",
month = "1",
day = "1",
doi = "10.1210/jcem-72-4-883",
language = "English (US)",
volume = "72",
pages = "883--887",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "4",

}

TY - JOUR

T1 - Effect of acute physiological elevations of insulin on circulating androgen levels in nonobese women

AU - Diamondf, Michael P.

AU - Grainger, David A.

AU - Laudano, Andrea J.

AU - Starick-Zych, Kathleen

AU - Defronzo, Ralph A.

PY - 1991/1/1

Y1 - 1991/1/1

N2 - Extreme pharmacological elevation of the circulating insulin level acutely lowers dehydroepiandrosterone sulfate (DHEAS) levels. To assess whether more physiological elevations in plasma insulin (due to exogenous infusion or endogenous secretion) would have similar effects, we examined the levels of DHEAS, androstenedione, testosterone, and free testosterone before and after euglycemic hyperinsulinemic and hyperglycemic hyperinsulinemic clamp studies. Studies were performed in women within 20% of ideal body weight after an overnight fast. Androgen levels were measured before and at the conclusion of studies in which either insulin was infused exogenously at 1 mU/kg·min or endogenous insulin secretion was stimulated for 2 h by elevation of the plasma glucose concentration by 125 mg/dL above basal levels by an exogenous glucose infusion. Basal plasma DHEAS (6.2 ± 0.5 μmol/L) declined to 5.2 ± 0.4 μmol/L (P < 0.001) during the euglycemic insulin clamp, without any significant change in testosterone, free testosterone, or androstenedione. During the hyperglycemic clamp, DHEAS fell from 6.7 ± 0.5 to 5.1 ± 0.4 μmol/h (P < 0.001) in response to endogenous hyperinsulinemia; plasma testosterone, free testosterone, and androstenedione did not change significantly. There was no correlation between the elevation in plasma insulin concentration and the fall in DHEAS during either the euglycemic or hyperglycemic clamps. However, the magnitude of fall of DHEAS was directly correlated with the initial DHEAS level in both the euglycemic (r = 0.51; P < 0.05) and hyperglycemic (r = 0.75; P < 0.01) studies. This association of hyperinsulinemia with a reduction of circulating levels of DHEAS, but not other C-19 steroids (e.g. testosterone and androstenedione) may reflect differential mechanisms by which DHEAS levels are regulated and suggests that insulin either inhibits its biosynthesis and/or secretion, or enhances its MCR.

AB - Extreme pharmacological elevation of the circulating insulin level acutely lowers dehydroepiandrosterone sulfate (DHEAS) levels. To assess whether more physiological elevations in plasma insulin (due to exogenous infusion or endogenous secretion) would have similar effects, we examined the levels of DHEAS, androstenedione, testosterone, and free testosterone before and after euglycemic hyperinsulinemic and hyperglycemic hyperinsulinemic clamp studies. Studies were performed in women within 20% of ideal body weight after an overnight fast. Androgen levels were measured before and at the conclusion of studies in which either insulin was infused exogenously at 1 mU/kg·min or endogenous insulin secretion was stimulated for 2 h by elevation of the plasma glucose concentration by 125 mg/dL above basal levels by an exogenous glucose infusion. Basal plasma DHEAS (6.2 ± 0.5 μmol/L) declined to 5.2 ± 0.4 μmol/L (P < 0.001) during the euglycemic insulin clamp, without any significant change in testosterone, free testosterone, or androstenedione. During the hyperglycemic clamp, DHEAS fell from 6.7 ± 0.5 to 5.1 ± 0.4 μmol/h (P < 0.001) in response to endogenous hyperinsulinemia; plasma testosterone, free testosterone, and androstenedione did not change significantly. There was no correlation between the elevation in plasma insulin concentration and the fall in DHEAS during either the euglycemic or hyperglycemic clamps. However, the magnitude of fall of DHEAS was directly correlated with the initial DHEAS level in both the euglycemic (r = 0.51; P < 0.05) and hyperglycemic (r = 0.75; P < 0.01) studies. This association of hyperinsulinemia with a reduction of circulating levels of DHEAS, but not other C-19 steroids (e.g. testosterone and androstenedione) may reflect differential mechanisms by which DHEAS levels are regulated and suggests that insulin either inhibits its biosynthesis and/or secretion, or enhances its MCR.

UR - http://www.scopus.com/inward/record.url?scp=0025771972&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025771972&partnerID=8YFLogxK

U2 - 10.1210/jcem-72-4-883

DO - 10.1210/jcem-72-4-883

M3 - Article

C2 - 1826009

AN - SCOPUS:0025771972

VL - 72

SP - 883

EP - 887

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 4

ER -